Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
Public ClinicalTrials.gov record NCT03187769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults With Schizophrenia, Schizophreniform, or Bipolar I Disorder Who Are Early in Their Illness
Study identification
- NCT ID
- NCT03187769
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Alkermes, Inc.
- Industry
- Enrollment
- 426 participants
Conditions and interventions
Interventions
- ALKS 3831 Drug
- Olanzapine Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years to 40 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 7, 2017
- Primary completion
- Nov 30, 2021
- Completion
- Jan 2, 2022
- Last update posted
- Jan 18, 2023
2017 – 2022
United States locations
- U.S. sites
- 25
- U.S. states
- 11
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alkermes Investigational Site | Little Rock | Arkansas | 72211 | — |
| Alkermes Investigational Site | Rogers | Arkansas | 72758 | — |
| Alkermes Investigational Site | Garden Grove | California | 92845 | — |
| Alkermes Investigational Site | San Diego | California | 92013 | — |
| Alkermes Investigational Site | Stanford | California | 94305 | — |
| Alkermes Investigational Site | Jacksonville | Florida | 32209 | — |
| Alkermes Investigational Site | North Miami | Florida | 33161 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30303 | — |
| Alkermes Investigational Site | Atlanta | Georgia | 30331 | — |
| Alkermes Investigational Site | Augusta | Georgia | 30912 | — |
| Alkermes Investigational Site | Chicago | Illinois | 60611 | — |
| Alkermes Investigational Site | Winfield | Illinois | 60190 | — |
| Alkermes Investigational Site | Kalamazoo | Michigan | 49001 | — |
| Alkermes Investigational Site | Kansas City | Missouri | 64108 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63110 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63118 | — |
| Alkermes Investigational Site | St Louis | Missouri | 63128 | — |
| Alkermes Investigational Site | Las Vegas | Nevada | 89102 | — |
| Alkermes Investigational Site | Cincinnati | Ohio | 45219 | — |
| Alkermes Investigational Site | Eugene | Oregon | 97401 | — |
| Alkermes Investigational Site | DeSoto | Texas | 75115 | — |
| Alkermes Investigational Site | Fort Worth | Texas | 76104 | — |
| Alkermes Investigational Site | Houston | Texas | 77030 | — |
| Alkermes Investigational Site | Richardson | Texas | 75080 | — |
| Alkermes Investigational Site | San Antonio | Texas | 78201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03187769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03187769 live on ClinicalTrials.gov.